BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19846968)

  • 1. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.
    Csejtei A; Tibold A; Koltai K; Varga Z; Szanyi I; Gobel G; Prantner I; Steffler D; Feher G; De Blasio A; Ember I; Kiss I
    Anticancer Res; 2009 Oct; 29(10):4169-73. PubMed ID: 19846968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
    Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
    Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair gene XRCC1 polymorphisms and outcome of renal cell carcinoma in Caucasian patients.
    Bachmann HS; Rübben H; Schmid KW; Siffert W; Riemann K
    Anticancer Res; 2009 Dec; 29(12):5131-5. PubMed ID: 20044627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
    J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
    Yang SF; Xu YJ; Xie JG; Zhang ZX
    Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.
    Chung HH; Kim MK; Kim JW; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2006 Dec; 103(3):1031-7. PubMed ID: 16875718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
    Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
    Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas.
    Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
    Cancer; 2007 Jul; 110(2):318-25. PubMed ID: 17559126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
    Ruwali M; Khan AJ; Shah PP; Singh AP; Pant MC; Parmar D
    Environ Mol Mutagen; 2009 Jul; 50(6):473-82. PubMed ID: 19334053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples.
    Majumder M; Indra D; Roy PD; Datta S; Ray JG; Panda CK; Roy B
    J Oral Pathol Med; 2009 Feb; 38(2):174-80. PubMed ID: 18764855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic polymorphism in patients with colorectal and with head and neck cancer].
    Csejtei A; Tibold A; Ember I; Kiss I
    Orv Hetil; 2009 Aug; 150(33):1545-9. PubMed ID: 19643719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
    Pratesi N; Mangoni M; Mancini I; Paiar F; Simi L; Livi L; Cassani S; Buglione M; Grisanti S; Almici C; Polli C; Saieva C; Magrini SM; Biti G; Pazzagli M; Orlando C
    Radiother Oncol; 2011 Jun; 99(3):356-61. PubMed ID: 21704413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease.
    Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
    Neurosci Lett; 2008 Sep; 442(3):287-91. PubMed ID: 18672023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck.
    Kowalski M; Przybylowska K; Rusin P; Olszewski J; Morawiec-Sztandera A; Bielecka-Kowalska A; Pietruszewska W; Mlynarski W; Janusz S; Majsterek I
    J Exp Clin Cancer Res; 2009 Mar; 28(1):37. PubMed ID: 19284666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Jahnke K; Lang S; Schmid KW; Siffert W; Frey UH
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3203-7. PubMed ID: 18990763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
    Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.